We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Detection Kit to Aid Diagnosis of Lung Cancer

By HospiMedica staff writers
Posted on 01 Jul 2005
New data from an expanded comprehensive clinical study have demonstrated high sensitivity and specificity of a detection kit designed for the diagnosis of lung cancer. More...
The data were presented at the World Biomarker Congress in May 2005 in Philadelphia (PA, USA).

The CellCorrect LAb detection kit was developed by CeMines, Inc. (Golden, CO, USA). The updated data also demonstrated the presence of diagnostically informative autoantibodies in the blood of breast, colon, and stomach cancer patients. The company has announced the filing of two patents claiming specific design and delivery of molecules that interfere with transcriptional mechanisms. CeMines believes this intellectual property will play a key role in the company's development of drugs to treat different types of cancer.

CellCorrect LAb detects altered autoimmunity and associated patterns of disease-related autoantibodies in the bloodstream. Extensive studies have demonstrated that specific and consistent patterns of certain antibodies have regularly proven their utility as composite biomarkers to characterize cancer, states CeMines, and can therefore be used as diagnostic tests for cancer. The company uses a proprietary bioinformatics-based statistical pattern-recognition application called Molecular Fingerprinting, which evaluates the patterns of certain antibodies in the profiles of cancer patients.




Related Links:
CeMines

Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Patient Preoperative Skin Preparation
BD ChloraPrep
Tourniquet System
heidi– mein Tourniquet
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: LigaSure RAS Maryland, designed for the Valleylab FT10 platform on Hugo RAS, seals and cuts vessels, tissue, and lymphatics up to 7 mm in diameter (Photo courtesy of Medtronic)

Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery

As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.